Joshua R. Disbrow

Chief Executive Officer at Aytu BioPharma Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Aytu BioPharma Inc., 3 years.

Aytu BioPharma Inc. Director · Chief Executive Officer
3 years · Since 2023

Chief executive roles

Aytu BioPharma Inc. · Chief Executive Officer
Dates unknown

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 28, 2026 Aytu BioPharma Inc. Grant or award +30,000 — —
Oct 3, 2025 Aytu BioPharma Inc. Grant or award +31,446 — —
Oct 3, 2025 Aytu BioPharma Inc. Grant or award +22,500 — —
Jun 9, 2025 Aytu BioPharma Inc. Open-market purchase +66,666 $1.50 $99,999
Feb 28, 2025 Aytu BioPharma Inc. Open-market purchase +15,000 $1.30 $19,500
Jun 14, 2023 Aytu BioPharma Inc. Open-market purchase +14,000 $1.86 $26,040

Questions about Joshua R. Disbrow

What boards is Joshua R. Disbrow on?

Joshua R. Disbrow sits on the board of Aytu BioPharma Inc.

What company is Joshua R. Disbrow the CEO of?

Joshua R. Disbrow is Chief Executive Officer of Aytu BioPharma Inc.

How long has Joshua R. Disbrow served on boards?

Our records show at least 3 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.